phosphocitrate has been researched along with bafilomycin a1 in 1 studies
| Studies (phosphocitrate) | Trials (phosphocitrate) | Recent Studies (post-2010) (phosphocitrate) | Studies (bafilomycin a1) | Trials (bafilomycin a1) | Recent Studies (post-2010) (bafilomycin a1) |
|---|---|---|---|---|---|
| 51 | 0 | 6 | 1,120 | 1 | 484 |
| Protein | Taxonomy | phosphocitrate (IC50) | bafilomycin a1 (IC50) |
|---|---|---|---|
| P2X purinoceptor 3 | Homo sapiens (human) | 0.755 | |
| V-type proton ATPase subunit S1 | Homo sapiens (human) | 0.1 | |
| Vacuolar proton pump subunit B | Gallus gallus (chicken) | 0.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooke, MM; McCarthy, GM; Morgan, MP; Sallis, JD | 1 |
1 other study(ies) available for phosphocitrate and bafilomycin a1
| Article | Year |
|---|---|
Phosphocitrate inhibits calcium hydroxyapatite induced mitogenesis and upregulation of matrix metalloproteinase-1, interleukin-1beta and cyclooxygenase-2 mRNA in human breast cancer cell lines.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Breast Neoplasms; Calcinosis; Cell Division; Citrates; Cyclooxygenase 2; Dinoprostone; Durapatite; Gene Expression Regulation, Neoplastic; Humans; Interleukin-1; Isoenzymes; Macrolides; Matrix Metalloproteinase 1; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; RNA, Messenger; Tumor Cells, Cultured; Up-Regulation | 2003 |